Indian Market Report for Anti-Adhesion Products - MedCore
|出版商||iData Research Inc.||商品編碼||360644|
|出版日期||內容資訊||英文 31 Pages
|印度的防沾黏貼片市場分析 Indian Market Report for Anti-Adhesion Products - MedCore|
|出版日期: 2016年05月01日||內容資訊: 英文 31 Pages||
所謂防沾黏貼片 (抗黏劑) ，是將手術中的粘連發生控制在最低限度的產品。各種手術 (婦產科、腹部、整形外科、心臟、神經等) 中，往往產生組織間由於纖維質纏繞互相粘連的現象。還有在外傷的自然治癒的過程發生。產生粘連的患者中，必須進一步治療的僅有5％，不過，30％前後的患者回答感到某種不舒服。據信小腸阻塞 (SBO)的65％，慢性骨盆疼痛的35％，不孕症的20％，原因是粘連。
本報告提供印度國內的防沾黏貼片 (防止附著產品)的市場相關分析，整體市場規模的變化及預測 (過去4年、今後7年份)，各產品詳細趨勢等調查、估計，主要的推動及阻礙市場要素，近幾年的企業間競爭情勢的資訊彙整，為您概述為以下內容。
The anti-adhesion market, also referred to as the adhesion prevention market, includes products aimed at minimizing surgical adhesions. Surgical adhesions are fibrous bands that form between tissues and organs, often as a result of injury during surgery. These adhesions can be formed during any type of surgery, including gynecological, abdominal, orthopedic, cardiac and neurological procedures. Adhesions are often thought of as internal scar tissue and are a side effect of the body's natural healing process. For example, up to 93% of patients who undergo intra-abdominal surgery develop adhesions. The majority of adhesions are asymptomatic; however, approximately 5% of adhesions result in severe symptoms such as pain, small bowel obstruction (SBO), range of motion restriction and/or infertility. While only 5% of adhesions result in symptoms severe enough to require further treatment, as many as 30% are thought to cause low level discomfort that is tolerated by the patient. Adhesions are believed to be responsible for approximately 65% of all SBO, 35% of chronic pelvic pain and 20% of infertility diagnoses.